Biomed Central Ltd

SHERPA: Unknown

People

  1. Wolchok
    Wolchok
  2. Merghoub
    Merghoub
  3. Postow
    Postow
  4. Vickers
    Vickers
  5. Budhu
    Budhu
  6. D'Angelo
    D'Angelo
  7. Offit
    Offit
  8. Motzer
    Motzer
  9. Shoushtari
    Shoushtari
  10. Cheung
    Cheung

Groups

  1. Department of Medicine (515)
  2. Solid Tumor Oncology Division (422)
  3. GSK Faculty (276)
  4. Sloan Kettering Institute Postdocs (174)
  5. Epidemiology and Biostatistics (143)
  6. Population Sciences Research Program (143)
  7. Melanoma and Immunotherapeutics Service (142)
  8. Hematologic Malignancies, Division of (140)
  9. Sloan Kettering Institute Faculty (120)
  10. Surgery (111)
Search Within
Formats
  1. Journal Article (664)
  2. Meeting Abstract (258)
  3. Review (32)
  4. Guidelines (18)
  5. Editorial (7)
  6. Research Letter (6)
  7. Conference Paper (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (515)
  2. Solid Tumor Oncology Division (422)
  3. GSK Faculty (276)
  4. Sloan Kettering Institute Postdocs (174)
  5. Epidemiology and Biostatistics (143)
  6. Population Sciences Research Program (143)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Michael Postow (42)
  4. Andrew Vickers (41)
  5. Matthew Hellmann (29)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2023 (39)
  2. 2022 (123)
  3. 2021 (91)
  4. 2020 (99)
  5. 2019 (72)
  6. 2018 (59)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (381)
  2. BMC Cancer (61)
  3. Breast Cancer Research (60)
  4. Genome Biology (41)
  5. Journal of Hematology & Oncology (34)
  6. Journal of Translational Medicine (34)

More Publications

Results (987)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
    Journal Article

    Epperla, N.; Feng, L.; Shah, N. N.; Fitzgerald, L.; Shah, H.; Stephens, D. M.; Lee, C. J.; Ollila, T.; Shouse, G.; Danilov, A. V.; more...
    Journal of Hematology & Oncology (2023)

    Fulltext@MSK | Save
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI
    Journal Article

    Woo, S.; Becker, A. S.; Das, J. P.; Ghafoor, S.; Arita, Y.; Benfante, N.; Gangai, N.; Teo, M. Y.; Goh, A. C.; Vargas, H. A.
    Cancer Imaging (2023)

    Fulltext@MSK | Save
  • Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot flashes in prostate cancer (AVAIL): Study protocol for a randomized clinical trial
    Journal Article

    Qin, Z.; Zang, Z.; Yu, J.; Lv, J.; Li, N.; Zhang, J.; Yang, M.; Kwong, J. S. W.; Pang, R.; Wang, J.; more...
    BMC Complementary Medicine & Therapies (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
    Guidelines

    Pavlick, A. C.; Ariyan, C. E.; Buchbinder, E. I.; Davar, D.; Gibney, G. T.; Hamid, O.; Hieken, T. J.; Izar, B.; Johnson, D. B.; Kulkarni, R. P.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Review

    Pekala, K. R.; Bergengren, O.; Eastham, J. A.; Carlsson, S. V.
    BMC Urology (2023)

    Fulltext@MSK | Save
  • Predicting tumour content of liquid biopsies from cell-free DNA
    Journal Article

    Cardner, M.; Marass, F.; Gedvilaite, E.; Yang, J. L.; Tsui, D. W. Y.; Beerenwinkel, N.
    BMC Bioinformatics (2023)

    Fulltext@MSK | Save
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save